全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression

DOI: 10.1177/2048872616675485

Keywords: ECMO support,transcatheter techniques,cardiogenic shock,haemodynamics,pulmonary oedema,outcomes

Full-Text   Cite this paper   Add to My Lib

Abstract:

Transcatheter techniques are emerging for left atrial (LA) decompression under venoarterial extracorporeal membrane oxygenation (VA-ECMO). We aimed to assess whether balloon atrioseptostomy (BAS) is a safe and efficient strategy. All patients who underwent percutaneous static BAS under VA-ECMO at four tertiary institutions were retrospectively reviewed. From 2000 to 2014, BAS was performed in 64 patients (32 adults and 32 children). Indications for ECMO support included acute myocarditis (31.3%) and non-myocarditis cardiac disease, mostly end-stage dilated cardiomyopathy (32.8%). BAS was required because of pulmonary oedema/haemorrhage and left ventricular (LV) distension. The mean balloon diameter was 21.8?±?8.4mm. Adequate LA decompression was achieved in all patients. Mean LA pressure fell from 24.2?±?6.9?mmHg to 7.8?±?2.6?mmHg (p?<?0.001). The left-to-right atrial pressure gradient fell from 17.2?±?7.1?mmHg to 0.09?±?0.5?mmHg (p?<?0.001). Echocardiography showed an unrestrictive left-to-right atrial shunting in all patients. Improvement of day?1 chest X-ray was observed in 76.6% of patients, clinical status in 98.4% of patients and pulmonary haemorrhage in 14 out of 14 patients. Complications occurred in 9.4% of patients, representing pericardial effusion, fast atrial fibrillation, ventricular fibrillation requiring defibrillation, transient complete heart block and femoral venous dissection requiring covered stent placement. In the 37 (57.8%) patients who were successfully decannulated, the median ECMO duration was 9 (range: 4–24) days. After a median follow-up of 12.3 (range: 0.1–142) months, 35.9% patients died, 17.2% received a LV assist device as a bridge to transplantation, 31.2% were transplanted and 56.2% were home discharged and alive. Percutaneous BAS may be a safe and efficient strategy for discharging the LA in both adults and children supported by VA-ECMO

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133